Literature DB >> 20103736

IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach.

Paolo Denti1, Alessandra Bertoldo, Paolo Vicini, Claudio Cobelli.   

Abstract

Population approaches, traditionally employed in pharmacokinetic-pharmacodynamic studies, have shown value also in the context of glucose-insulin metabolism models by providing more accurate individual parameters estimates and a compelling statistical framework for the analysis of between-subject variability (BSV). In this work, the advantages of population techniques are further explored by proposing integration of covariates in the intravenous glucose tolerance test (IVGTT) glucose minimal model analysis. A previously published dataset of 204 healthy subjects, who underwent insulin-modified IVGTTs, was analyzed in NONMEM, and relevant demographic information about each subject was employed to explain part of the BSV observed in parameter values. Demographic data included height, weight, sex, and age, but also basal glycemia and insulinemia, and information about amount and distribution of body fat. On the basis of nonlinear mixed-effects modeling, age, visceral abdominal fat, and basal insulinemia were significant predictors for SI (insulin sensitivity), whereas only age and basal insulinemia were significant for P2 (insulin action). The volume of distribution correlated with sex, age, percentage of total body fat, and basal glycemia, whereas no significant covariate was detected to explain variability in SG (glucose effectiveness). The introduction of covariates resulted in a significant shrinking of the unexplained BSV, especially for SI and P2 and considerably improved the model fit. These results offer a starting point for speculation about the physiological meaning of the relationships detected and pave the way for the design of less invasive and less expensive protocols for epidemiological studies of glucose-insulin metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103736      PMCID: PMC2867373          DOI: 10.1152/ajpendo.00656.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  29 in total

1.  The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling. Intravenous glucose tolerance test.

Authors:  P Vicini; C Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-01       Impact factor: 4.310

2.  Assessment of actual significance levels for covariate effects in NONMEM.

Authors:  U Wählby; E N Jonsson; M O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-06       Impact factor: 2.745

3.  Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Authors:  Yoshinori Miyazaki; Leonard Glass; Curtis Triplitt; Estela Wajcberg; Lawrence J Mandarino; Ralph A DeFronzo
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-12       Impact factor: 4.310

4.  Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.

Authors:  Ulrika Wählby; E Niclas Jonsson; Mats O Karlsson
Journal:  AAPS PharmSci       Date:  2002

5.  Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

Authors:  Lars Lindbom; Jakob Ribbing; E Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2004-08       Impact factor: 5.428

6.  Population and individual minimal modeling of the frequently sampled insulin-modified intravenous glucose tolerance test.

Authors:  Lars Erichsen; Olorunsola F Agbaje; Stephen D Luzio; David R Owens; Roman Hovorka
Journal:  Metabolism       Date:  2004-10       Impact factor: 8.694

7.  Bayesian hierarchical approach to estimate insulin sensitivity by minimal model.

Authors:  Olorunsola F Agbaje; Stephen D Luzio; Ahmed I S Albarrak; David J Lunn; David R Owens; Roman Hovorka
Journal:  Clin Sci (Lond)       Date:  2003-11       Impact factor: 6.124

8.  Metabolic effects of visceral fat accumulation in type 2 diabetes.

Authors:  Amalia Gastaldelli; Yoshinori Miyazaki; Maura Pettiti; Masafumi Matsuda; Srihanth Mahankali; Eleonora Santini; Ralph A DeFronzo; Ele Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

9.  Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.

Authors:  Lynne E Wagenknecht; Carl D Langefeld; Ann L Scherzinger; Jill M Norris; Steven M Haffner; Mohammed F Saad; Richard N Bergman
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

10.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.

Authors:  Rita Basu; Elena Breda; Ann L Oberg; Claudia C Powell; Chiara Dalla Man; Ananda Basu; Janet L Vittone; George G Klee; Puneet Arora; Michael D Jensen; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

View more
  10 in total

1.  Visual Predictive Check in Models with Time-Varying Input Function.

Authors:  Anna Largajolli; Alessandra Bertoldo; Marco Campioni; Claudio Cobelli
Journal:  AAPS J       Date:  2015-08-12       Impact factor: 4.009

2.  Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined.

Authors:  Laura Pyle; Bryan C Bergman; Kristen J Nadeau; Melanie Cree-Green
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

3.  Variability in Estimated Modelled Insulin Secretion.

Authors:  Jennifer J Ormsbee; Hannah J Burden; Jennifer L Knopp; J Geoffrey Chase; Rinki Murphy; Peter R Shepherd; Troy Merry
Journal:  J Diabetes Sci Technol       Date:  2021-02-15

4.  Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.

Authors:  Kaoru Ohashi; Hisako Komada; Shinsuke Uda; Hiroyuki Kubota; Toshinao Iwaki; Hiroki Fukuzawa; Yasunori Komori; Masashi Fujii; Yu Toyoshima; Kazuhiko Sakaguchi; Wataru Ogawa; Shinya Kuroda
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

Review 5.  Quantitative approaches to energy and glucose homeostasis: machine learning and modelling for precision understanding and prediction.

Authors:  Thomas McGrath; Kevin G Murphy; Nick S Jones
Journal:  J R Soc Interface       Date:  2018-01-24       Impact factor: 4.118

6.  Modeling Between-Subject Variability in Subcutaneous Absorption of a Fast-Acting Insulin Analogue by a Nonlinear Mixed Effects Approach.

Authors:  Edoardo Faggionato; Michele Schiavon; Chiara Dalla Man
Journal:  Metabolites       Date:  2021-04-12

7.  An Analysis of Glucose Effectiveness in Subjects With or Without Type 2 Diabetes via Hierarchical Modeling.

Authors:  Shihao Hu; Yuzhi Lu; Andrea Tura; Giovanni Pacini; David Z D'Argenio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

Review 8.  Pharmacometrics Approaches and its Applications in Diabetes: An Overview.

Authors:  Sohail Aziz; Sabariah Noor Harun; Syed Azhar Syed Sulaiman; Siti Maisharah Sheikh Ghadzi
Journal:  J Pharm Bioallied Sci       Date:  2022-03-04

Review 9.  Measuring and estimating insulin resistance in clinical and research settings.

Authors:  Amalia Gastaldelli
Journal:  Obesity (Silver Spring)       Date:  2022-08       Impact factor: 9.298

10.  Modelling the effects of glucagon during glucose tolerance testing.

Authors:  Ross A Kelly; Molly J Fitches; Steven D Webb; S R Pop; Stewart J Chidlow
Journal:  Theor Biol Med Model       Date:  2019-12-12       Impact factor: 2.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.